We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $672B
1-Year Est. Return 33.48%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
+33.48%
3 Year Est. Return
+94.84%
5 Year Est. Return
+111.06%
10 Year Est. Return
+380.55%
AUM
$381B
AUM Growth
+$27.2B
Cap. Flow
+$10.3B
Cap. Flow %
2.7%
Top 10 Hldgs %
19.31%
Holding
8,037
New
676
Increased
3,797
Reduced
2,511
Closed
409

Sector Composition

Rank Sector Weight
1 Financials 18.63%
2 Technology 14.62%
3 Industrials 7.95%
4 Healthcare 7.93%
5 Energy 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BH icon
6001
Biglari Holdings Class B
BH
$1.21B
$24K ﹤0.01%
125
CARM
6002
DELISTED
Carisma Therapeutics
CARM
$24K ﹤0.01%
2,781
+2,616
+1,585% +$14.2K
EGAN icon
6003
eGain
EGAN
$206M
$24K ﹤0.01%
3,095
-1,075
-26% -$7.82K
ESPR
6004
DELISTED
Esperion Therapeutics
ESPR
$24K ﹤0.01%
17,173
-5,055
-23% -$7.06K
EUDV icon
6005
ProShares MSCI Europe Dividend Growers ETF
EUDV
$8.51M
$24K ﹤0.01%
538
FRHC icon
6006
Freedom Holding
FRHC
$9.34B
$24K ﹤0.01%
295
-357
-55% -$28.1K
GCBC icon
6007
Greene County Bancorp
GCBC
$595M
$24K ﹤0.01%
817
+241
+42% +$5.8K
HBIO icon
6008
Harvard Bioscience
HBIO
$30.3M
$24K ﹤0.01%
445
+444
+44,400% +$24.4K
INFA
6009
DELISTED
Informatica
INFA
$24K ﹤0.01%
1,294
+109
+9% +$1.8K
IQ icon
6010
iQIYI
IQ
$1.3B
$24K ﹤0.01%
4,394
-5,626
-56% -$31.6K
KNOP icon
6011
KNOT Offshore Partners
KNOP
$369M
$24K ﹤0.01%
4,659
+337
+8% +$1.67K
KOD icon
6012
Kodiak Sciences
KOD
$2.59B
$24K ﹤0.01%
3,503
+1,476
+73% +$9.03K
NB
6013
NioCorp Developments
NB
$744M
$24K ﹤0.01%
4,601
-307
-6% -$1.75K
PRLD icon
6014
Prelude Therapeutics
PRLD
$443M
$24K ﹤0.01%
5,279
+21
+0.4% +$125
RWEM
6015
Rayliant NxtGen Multifactor Emerging Markets Equity ETF
RWEM
$72.6M
$24K ﹤0.01%
1,100
-100
-8% -$2.03K
SIGA icon
6016
SIGA Technologies
SIGA
$216M
$24K ﹤0.01%
4,860
+125
+3% +$711
SPRY icon
6017
ARS Pharmaceuticals
SPRY
$561M
$24K ﹤0.01%
3,594
+3,589
+71,780% +$24K
WPRT
6018
Westport Fuel Systems
WPRT
$33.4M
$24K ﹤0.01%
3,140
-20,627
-87% -$159K
WTV icon
6019
WisdomTree US Value Fund
WTV
$3.4B
$24K ﹤0.01%
383
WMPN
6020
DELISTED
William Penn Bancorporation Common Stock
WMPN
$24K ﹤0.01%
2,356
+334
+17% +$3.35K
IVAC
6021
DELISTED
Intevac Inc
IVAC
$24K ﹤0.01%
+6,527
New +$35K
CMAX
6022
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$24K ﹤0.01%
261
+125
+92% +$11K
BCTX
6023
Briacell Therapeutics
BCTX
$29.9M
$23K ﹤0.01%
+24
New +$23.7K
CAN
6024
Canaan Creative
CAN
$171M
$23K ﹤0.01%
10,810
-45
-0.4% -$109
CDLX icon
6025
Cardlytics
CDLX
$24.9M
$23K ﹤0.01%
367
+173
+89% +$10.5K

Similar funds

Royal Bank of Canada's Q2 2023 Portfolio in Review

As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Royal Bank of Canada's Q2 2023 filing shows 676 new, 3,797 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.

  • Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
  • Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
  • Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
  • Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
  • Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
  • Royal Bank of Canada opened 676 new positions and closed 409 in Q2 2023.
  • Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.

Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.